Calendar

Date TBD

SUSPENDEDphase readoutNCT06626633: 2321GCCC: CRD3874-SI in Patients With Relapsed/Refractory AML

Sponsor: University of Maryland, Baltimore. Phase: PHASE1. Conditions: Acute Myeloid Leukemia

COMPLETEDphase readoutNCT06608433: Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Healthy Volunteer Study, HPA, Cortisol Deficiency, Adrenal Insufficiency

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07494747: Evaluation of the Effect of the Toothpaste on Delicate Gums

Sponsor: Lacer S.A.. Phase: NA. Conditions: Gingivitis

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05837949: Multiple Sclerosis Falls Insight Track

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Multiple Sclerosis

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04547049: A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

Sponsor: First Affiliated Hospital of Zhejiang University. Phase: PHASE3. Conditions: Leukemia, MDS

full page →ctgov ↗

COMPLETEDphase readoutNCT07288658: Comparing the Fit and Performance of Scleral Lenses With Oval and Circular Limbal Zones

Sponsor: University of Waterloo. Phase: PHASE4. Conditions: Limbus Corneae

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT02043158: Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer

Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Ovarian Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT07227558: Improving Information Sharing Between Family Caregivers and Home Care Aides

Sponsor: Johns Hopkins Bloomberg School of Public Health. Phase: NA. Conditions: Shared Care

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07341048: Potential Biological and Physiological Determinants for Exercice in Patients With Polycythemia Vera

Sponsor: Hospices Civils de Lyon. Phase: NA. Conditions: Polycythemia, Polycythemia Vera (PV)

full page →ctgov ↗

RECRUITINGphase readoutNCT06008626: Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea

Sponsor: Cryosa, Inc.. Phase: NA. Conditions: Obstructive Sleep Apnea of Adult

full page →ctgov ↗

RECRUITINGphase readoutNCT07139626: Screening of Predictive Biomarkers for Cardiorenal Syndrome

Sponsor: Haiyan Pan. Phase: . Conditions: Cardiorenal Syndrome (CRS)

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07138885: A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular Carcinoma

Sponsor: Sun Yat-sen University. Phase: PHASE2. Conditions: Hepatocellular Carcinoma (HCC), Second Line Treatment

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03663543: Intravenous Estrogen in Kidney Transplant Study

Sponsor: University of Pennsylvania. Phase: PHASE1. Conditions: Ischemia Reperfusion Injury

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03962543: MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany. Phase: PHASE2. Conditions: Plexiform Neurofibroma, Neurofibromatosis Type 1 (NF1)

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT00001215: Genetic Studies of Lysosomal Storage Disorders

Sponsor: National Human Genome Research Institute (NHGRI). Phase: . Conditions: Lysosomal Storage Disorders, Gaucher Disease, Parkinson Disease

full page →ctgov ↗

RECRUITINGphase readoutNCT06572215: DYNAMic Renal Assessment: NOvel Methods to Assess KIDNEY Functional Reserve

Sponsor: King's College Hospital NHS Trust. Phase: . Conditions: Chronic Kidney Diseases

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07321535: Huangjing Yangji Formula Combined With Resistance Training for Sarcopenia

Sponsor: Wangjing Hospital, China Academy of Chinese Medical Sciences. Phase: NA. Conditions: Sarcopenia

full page →ctgov ↗

COMPLETEDphase readoutNCT07494708: Hemoglobin Drop and Need for Blood Transfusion in Primary Knee Arthroplasty With or Without Drain Insertion

Sponsor: Shifa International Hospital. Phase: NA. Conditions: Knee Osteoarthritis, Total Knee Arthroplasty

full page →ctgov ↗

RECRUITINGphase readoutNCT07201376: Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically

Sponsor: Dartmouth-Hitchcock Medical Center. Phase: . Conditions: Non-Melanoma Skin Cancer (NMSC), Benign Skin Growth

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07225725: Access to Care Pilot for ED-Presenting Head and Neck Cancer Patients (ENRICH-HNC)

Sponsor: University of Tennessee. Phase: NA. Conditions: Head and Neck Neoplasms, Emergency Department Presentation, Head and Neck Cancer (H&N)

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07544017: Patient Blood Management in Obstetrics

Sponsor: Corniche Hospital. Phase: . Conditions: Patient Blood Management, Blood Product Transfusion for All Conditions

full page →ctgov ↗

COMPLETEDphase readoutNCT07516717: Intrathecal Morphine 75 mcg Versus 100 mcg for Post-Cesarean Analgesia: A Randomized Double-blind Trial

Sponsor: Hospital Universitario de Caracas. Phase: PHASE4. Conditions: Postoperative Pain, Cesarean Section, Obstetric Anesthesia

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT01937468: Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

Sponsor: Dana-Farber Cancer Institute. Phase: PHASE1. Conditions: Chronic Graft Versus Host Disease, Chronic GVHD, Complications of Organ Transplant Stem Cells

full page →ctgov ↗

RECRUITINGphase readoutNCT06002789: Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University. Phase: PHASE2. Conditions: Multiple Cancer, Colorectal Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT07473089: Swiss Revision Cohort

Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: . Conditions: Joint (Knee or Hip Replacement), Infection as Complication of Medical Care

full page →ctgov ↗

RECRUITINGphase readoutNCT06581068: Automation of the In Vitro Fertilization Laboratory

Sponsor: Conceivable Life Sciences. Phase: NA. Conditions: Infertility, ART

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07468591: Spinal Cord Stimulation for Refractory Pain Randomized Controlled Trial: the PAcStim RCT

Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Chronic Pain Syndrome

full page →ctgov ↗

WITHHELDphase readoutNCT07168174: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗

RECRUITINGphase readoutNCT07233213: An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune Thrombocytopenia

Sponsor: Grand Shuyang Life Sciences (Chengdu) Co., Ltd.. Phase: PHASE3. Conditions: Primary Immune Thrombocytopenia (ITP)

full page →ctgov ↗

RECRUITINGphase readoutNCT06848660: Study on Orthosis in Cervical Spine Fracture Treatment

Sponsor: Uppsala University Hospital. Phase: NA. Conditions: Cervical Spine Fractures, Cervical Spine Injury, Rigid Collar

full page →ctgov ↗

RECRUITINGphase readoutNCT07428460: Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia

Sponsor: Douglas Mental Health University Institute. Phase: NA. Conditions: Schizophrenia and Predominant Negative Symptoms

full page →ctgov ↗

WITHDRAWNphase readoutNCT05829460: Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia

Sponsor: Washington University School of Medicine. Phase: PHASE2. Conditions: Endometrial Hyperplasia

full page →ctgov ↗

WITHHELDphase readoutNCT07524660: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗

RECRUITINGphase readoutNCT06818760: Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables

Sponsor: The Cleveland Clinic. Phase: . Conditions: Congenital Heart Disease, Congenital Vascular Disorder, Congenital Cardiomyopathy, Pregnancy Related

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07398560: Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study

Sponsor: The Third Affiliated Hospital of Harbin Medical University. Phase: PHASE2. Conditions: Small Cell Lung Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT06986460: Low Frequency Right Dorsolateral Pre Frontal Cortical Repetitive TMS for Bipolar Depression

Sponsor: Tyler Kaster. Phase: PHASE3. Conditions: Bipolar Depression Depressed Phase

full page →ctgov ↗

RECRUITINGphase readoutNCT05471960: Neuroplasticity in RBD

Sponsor: University of Minnesota. Phase: NA. Conditions: REM Sleep Behavior Disorder

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT06560021: Utility of Random Biopsies in Patients With Inflammatory Bowel Disease

Sponsor: Abramson Cancer Center at Penn Medicine. Phase: NA. Conditions: Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis

full page →ctgov ↗

RECRUITINGphase readoutNCT05724121: Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Chronic Lymphocytic Leukemia (CLL), Waldenstr(SqrRoot)(Delta)m s Macroglobulinemia, Mantle Cell Lymphoma, Sudden Cardiac Death, Cardiac Arrhythmias, Hematologic Malignancies

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT02656706: Adjuvant Nivolumab & Low Dose Ipilimumab for Stage III & Resected Stage IV Melanoma

Sponsor: Brown University. Phase: PHASE2. Conditions: Melanoma

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07430904: Empowerment Program to Reduce Treatment of Asymptomatic Bacteriuria in Veterans With Spinal Cord Injury

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Spinal Cord Injury, Spinal Cord Disease

full page →ctgov ↗

RECRUITINGphase readoutNCT07095933: The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy

Sponsor: Xuanwu Hospital, Beijing. Phase: EARLY_PHASE1. Conditions: Epilepsy, Drug Resistant

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06161584: A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Sponsor: Apellis Pharmaceuticals, Inc.. Phase: . Conditions: Geographic Atrophy

full page →ctgov ↗

RECRUITINGphase readoutNCT07509333: MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients

Sponsor: West China Hospital. Phase: NA. Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Elderly

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT07448233: Application of an AI-Based Health Management System in Long-Term Epilepsy Management in Rural Areas

Sponsor: Xijing Hospital. Phase: NA. Conditions: Epilepsies, Remote Management of Epilepsy in Rural Areas

full page →ctgov ↗

COMPLETEDphase readoutNCT02410733: Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma

Sponsor: BioNTech SE. Phase: PHASE1. Conditions: Melanoma

full page →ctgov ↗

RECRUITINGphase readoutNCT04128748: Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Acute Myeloid Leukemia, Blasts More Than 10 Percent of Bone Marrow Nucleated Cells, High Risk Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Acute Myeloid Leukemia, Refractory Myelodysplastic Syndrome

full page →ctgov ↗

RECRUITINGphase readoutNCT07144826: Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy

Sponsor: Ohio State University Comprehensive Cancer Center. Phase: EARLY_PHASE1. Conditions: Advanced Ovarian Carcinoma, Recurrent Ovarian Carcinoma, Stage II Ovarian Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT06206226: The Oh Happy Day Class - Digital Connections (OHDC-DC): A Pilot Study

Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Depression, Depressive Disorder, Depressive Symptoms

full page →ctgov ↗

COMPLETEDphase readoutNCT05116085: Efficacy and Safety of Tislelizumab (BGB-A317) as Neo-Adjuvant Treatment in Participants With Colorectal Cancer

Sponsor: BeiGene. Phase: PHASE2. Conditions: Colorectal Cancer

full page →ctgov ↗

← prev

page 17 of 77

Date TBD